Healthcare reform

ADEA Applauds Senate Bill to Permanently Allow Qualified Students to Vaccinate

Retrieved on: 
Thursday, June 17, 2021
Pharmaceutical, Training, White House, Federal Government, Healthcare reform, Infectious diseases, Continuing, Public policy, University, Education, Dental, Congressional News, Views, Health, Public policy, Government, American Dental Education Association, Osteopathic medicine in the United States, ADEA, ADEA, SAA, ADEA, SAA

The American Dental Education Association (ADEA) is hailing the introduction of a bill that would permanently allow qualified health professions students to administer vaccines during federally declared public health emergencies.

Key Points: 
  • The American Dental Education Association (ADEA) is hailing the introduction of a bill that would permanently allow qualified health professions students to administer vaccines during federally declared public health emergencies.
  • The legislation follows a year during which Students Assist America (SAA) , an interprofessional initiative of 12 health professions associations, including ADEA, advocated for allowing qualified students to help the U.S. health care workforce in times of crisis.
  • Permanently authorizing health professions students to vaccinate during emergencies as proposed by the SAVE Act will better protect our nations health and safety in the future.
  • Students Assist America (SAA) is an interprofessional initiative of 12 associations, including ADEA, spearheaded by the American Association of Colleges of Osteopathic Medicine.

CHPA Elects Johnson & Johnson’s Michelle Wang Goodridge as Board Chair

Retrieved on: 
Wednesday, June 16, 2021
Public relations, Investor relations, Congressional News, Views, Public policy, Government, Communications, Healthcare reform, Convenience store, Health, General Health, Retail, Health care, Health, CHPA, Consumer Healthcare Products Association, Johnson & Johnson, Goodridge, Over-the-counter drug

The Consumer Healthcare Products Association (CHPA) today announced the election of Michelle Wang Goodridge as the new Chair of the CHPA Board of Directors.

Key Points: 
  • The Consumer Healthcare Products Association (CHPA) today announced the election of Michelle Wang Goodridge as the new Chair of the CHPA Board of Directors.
  • View the full release here: https://www.businesswire.com/news/home/20210616005871/en/
    Michelle Wang Goodridge, President, U.S. Self Care at Johnson & Johnson Consumer Inc.
    Goodridge, a standing member of CHPAs Board of Directors since 2019, becomes the first female chair of the association.
  • Currently, Goodridge serves as President, U.S. Self Care at Johnson & Johnson Consumer Inc., overseeing the companys Self Care portfolio, including well-known over-the-counter (OTC) medicines and naturally inspired health and wellness products.
  • We are delighted to welcome Michelle to her new role as CHPA board chair, said Scott Melville, CHPA president and CEO.

U.S. Government Purchases Additional 200 Million Doses of Moderna’s COVID-19 Vaccine

Retrieved on: 
Wednesday, June 16, 2021
Research, Other Health, General Health, Pharmaceutical, Healthcare reform, Infectious diseases, Clinical trials, Science, Biotechnology, FDA, Health, Public policy, Government, Other Science, COVID-19, Medical research, COVID-19 vaccines, Clinical trials, RNA vaccines, Medicine, Health sciences, BioNTech, Moderna COVID-19 vaccine, Pfizer–BioNTech COVID-19 vaccine, Moderna, RNA vaccine, the Moderna COVID-19 Vaccine, Moderna, THE MODERNA COVID-19 VACCINE, MODERNA

Moderna, Inc., (Nasdaq: MRNA) a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced that the U.S. government has purchased an additional 200 million doses of Modernas COVID-19 vaccine, including the option to purchase other COVID-19 vaccine candidates from Modernas pipeline.

Key Points: 
  • Moderna, Inc., (Nasdaq: MRNA) a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced that the U.S. government has purchased an additional 200 million doses of Modernas COVID-19 vaccine, including the option to purchase other COVID-19 vaccine candidates from Modernas pipeline.
  • As of June 14, Moderna has supplied 217 million released doses of the vaccine to the U.S. government.
  • The Moderna COVID-19 Vaccine is an mRNA vaccine against COVID-19 encoding for a prefusion stabilized form of the Spike (S) protein.
  • Additional adverse reactions, some of which may be serious, may become apparent with more widespread use of the Moderna COVID-19 Vaccine.

 VIQ Solutions Hires Sales Leaders to Accelerate Growth in Insurance and Criminal Justice Industries

Retrieved on: 
Tuesday, June 15, 2021
Software, Professional services, Technology, Healthcare reform, Public policy, Security, Biotechnology, Insurance, Audio, Video, Other Technology, Health, Public policy, Government, Consulting, Articles, Economy, Economic growth, Manufacturing, Productivity, Innovation, BlackBerry Limited, Business economics

She brings nearly 15 years of industry experience, with past roles in sales productivity, account management, and business development.

Key Points: 
  • She brings nearly 15 years of industry experience, with past roles in sales productivity, account management, and business development.
  • Stephen Gaus is appointed to Director of Sales, Criminal Justice and Partner Relations.
  • Through bold innovation and thoughtful risk-taking our leadership team has positioned VIQ for the significant growth of our world-class solutions and services, said Sebastien Par, VIQ Chief Executive Officer.
  • VIQ Solutions is a global provider of secure, AI-driven, digital voice and video capture technology and transcription services.

Peiffer Wolf: $15 Million Award From Jury in Embryo-Destruction Case May Be First of Its Kind, Will Guide Handling of Hundreds of Other Victims

Retrieved on: 
Friday, June 11, 2021
Congressional News, Views, Professional services, Public policy, Government, Healthcare reform, State, Local, Legal, Fertility medicine, Reproduction, Human reproduction, Egg donation, Fertility, Medical specialties, Sperm donation, Human pregnancy, In vitro fertilisation, Fertility clinic

Peiffer Wolf Carr Kane & Conway (Peiffer Wolf), which is handling the cases of more than 100 Pacific Fertility Center victims, welcomed the jury award and said it would pave the way for justice for many others.

Key Points: 
  • Peiffer Wolf Carr Kane & Conway (Peiffer Wolf), which is handling the cases of more than 100 Pacific Fertility Center victims, welcomed the jury award and said it would pave the way for justice for many others.
  • In the last seven years, Peiffer Wolf has handled hundreds of IVF/genetic material cases that have involved well over 1,000 people.
  • In 2019, the firm spearheaded the Peiffer Wolf push for national legislation to rein in the abuses of IVF and fertility clinics .
  • There are about 200 other Pacific Fertility Center victims who are awaiting their day in court or in arbitration proceedings.

STATEMENT: Civica Rx Supports Biden Administration Recommendations for Strengthening the Pharmaceutical Supply Chain

Retrieved on: 
Tuesday, June 8, 2021
Managed care, Other Health, General Health, Supply chain management, Pharmaceutical, White House, Federal Government, Healthcare reform, Hospitals, Other Policy Issues, Retail, Practice Management, Health, Public policy, Government, Civica Rx, Health care, Health, Life sciences

Civica Rx (Civica, Inc.) welcomes the findings of the 100-day supply chain review .

Key Points: 
  • Civica Rx (Civica, Inc.) welcomes the findings of the 100-day supply chain review .
  • The report identifies key vulnerabilities in the generic drug supply chain that contribute to drug shortages and supply risks during a global public health emergency.
  • Eleven Civica medications have been used to help care for COVID-19 patients, including neuromuscular blocking agents, sedatives, pain management medications, and blood thinners.
  • Civica now over 50 different generic medications available for hospitals in multiple dosage forms and is building towards 100 drugs by 2023.

The Joint Commission, National Quality Forum Announce 2020 Eisenberg Award Recipients

Retrieved on: 
Tuesday, June 8, 2021
Public policy, Government, Health, Healthcare reform, Other Health, General Health, Research, Science, Health, National Quality Forum, Health care quality, Patient safety, Joint Commission, Health care, Patient safety organization, Hospital accreditation, The Joint Commission, National Quality Forum, THE JOINT COMMISSION, NATIONAL QUALITY FORUM

The Joint Commission and National Quality Forum (NQF), two of the nations leading organizations in health care quality and patient safety, today announced the recipients of the 2020 John M. Eisenberg Patient Safety and Quality Awards.

Key Points: 
  • The Joint Commission and National Quality Forum (NQF), two of the nations leading organizations in health care quality and patient safety, today announced the recipients of the 2020 John M. Eisenberg Patient Safety and Quality Awards.
  • This years Eisenberg Award recipients represent the best of the best in health care quality and safety improvement, said David W. Baker, MD, MPH, FACP, executive vice president, Division of Health Care Quality Evaluation, The Joint Commission.
  • An independent, nonprofit organization, The Joint Commission is the nations oldest and largest standards-setting and accrediting body in health care.
  • The National Quality Forum (NQF) works with members of the healthcare community to drive measurable health improvements together.

Wolters Kluwer Launches Telemedicine Value Sets for Payers and Providers to Thrive Post-COVID

Retrieved on: 
Tuesday, June 8, 2021
Technology, Professional services, Health, General Health, Healthcare reform, Other Technology, Telecommunications, Internet, Public policy, Government, Insurance, Mobile, Wireless, Articles, Technology, Health informatics, Science and technology, Assistive technology, Alphen aan den Rijn, Wolters Kluwer, Telehealth

In response, Wolters Kluwer, Health today released telehealth-specific value sets for use in health insurance claims processing, coordination of care, and benefits systems.

Key Points: 
  • In response, Wolters Kluwer, Health today released telehealth-specific value sets for use in health insurance claims processing, coordination of care, and benefits systems.
  • For providers embracing telehealth, these value sets can help stratify patient populations to identify those most likely to benefit.
  • Additionally, Wolters Kluwer offers Emmi , a solution that helps providers connect with patients at scale while providing a personalized and human experience.
  • Wolters Kluwer provides trusted clinical technology and evidence-based solutions that engage clinicians, patients, researchers and students in effective decision-making and outcomes across healthcare.

UN Must Heed the Lessons of AIDS Pandemic to End COVID-19, says AHF

Retrieved on: 
Tuesday, June 8, 2021
White House, Federal Government, AIDS, Public policy, Government, Health, Healthcare reform, Infectious diseases, Pharmaceutical, Medical specialties, Health, Medicine, HIV/AIDS activism, Vaccine, HIV/AIDS

Only by pushing the limits of conventional health policy, leadership and innovation was unbridled AIDS activism able to put the brakes on a pandemic and save millions of lives.

Key Points: 
  • Only by pushing the limits of conventional health policy, leadership and innovation was unbridled AIDS activism able to put the brakes on a pandemic and save millions of lives.
  • Today, we need the same level of boldness from our leaders on COVID-19, said AHF President Michael Weinstein.
  • In addition to generic antiretrovirals becoming widely available, another defining moment of AIDS history was the creation of the Global Fund to Fight AIDS, Tuberculosis and Malaria (GFATM).
  • As with AIDS, whether the world can deliver equitable vaccine access is a matter of political will.

AHF: Lessons from 40 Years of AIDS, ‘The Other Pandemic,’ Must Guide Global Response to COVID-19

Retrieved on: 
Friday, June 4, 2021
White House, Federal Government, AIDS, Public policy, Government, Health, Healthcare reform, Public policy, Infectious diseases, Medical specialties, Health, Azides, Hepatotoxins, Zidovudine, HIV/AIDS, Chemical substances, AIDS Healthcare Foundation

Forty years of painful lessons from AIDS offer applicable lessons for our global fight against COVID-19, lessons that should not be ignored, said Michael Weinstein, president of AHF.

Key Points: 
  • Forty years of painful lessons from AIDS offer applicable lessons for our global fight against COVID-19, lessons that should not be ignored, said Michael Weinstein, president of AHF.
  • For years we have needed to radically overhaul and change the architecture of our global public health system and its structures.
  • Thankfully, the 1996 introduction of lifesaving combined drug antiretroviral therapies (ART)the so-called AIDS drug cocktail saved countless millions from death.
  • However, HIV/AIDS remains a deadly global health issue, taking the lives of nearly 700,000 people annually around the world.